The Math Behind Delighting Ten Billion People
We chase one number — not revenue, not profit, but the number of people we have delighted. Ten thousand, a million, a hundred million — and ten billion. Yes, more than the world's population. Count person × occasion — delighted by our cosmetics, by their health, ten and twenty years on — and ten billion is almost modest.
Why count joy instead of sales? Order. Grow the count of delighted people, and revenue always follows; start counting from revenue, and a company eventually yields to the temptation of carving away joy to make numbers. What you count determines your company's character. In our meetings flies the question: "How many smiles is that?"
How many people did your work delight today? Start counting.
What do you work for?
— Tomoki Nagano, Chairman & CEO, INSTINCT BIO TECHNICAL COMPANY (NASDAQ: BIOT)
Next Essay
You Grow as Strong as the Number of Your Failures
Read →About the Company
The Nasdaq-listed company where the author serves as Chairman.
- Business →Stem-cell cosmetics R&D, OEM/ODM manufacturing, and in-house brands
- Investor Relations →BIOT stock price, SEC filings, and governance
- Company & Governance →Company profile and leadership
This series reflects the personal views of the author. It is not an earnings forecast, a valuation of any security, or a solicitation to invest.